Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2004, Vol. 103, No. 3, pp. 980-987.
Prepublished online as a Blood First Edition Paper on October 2, 2003; DOI 10.1182/blood-2003-03-0981.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-03-0981v1
103/3/980    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabriele, L.
Right arrow Articles by Belardelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gabriele, L.
Right arrow Articles by Belardelli, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted April 1, 2003
Accepted September 5, 2003

IFN-{alpha} promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment

Lucia Gabriele, Paola Borghi, Carmela Rozera, Paola Sestili, Mauro Andreotti, Anna Guarini, Enrico Montefusco, Robert Foa, and Filippo Belardelli*

Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy
Department of Cellular Biotechnologies and Hematology, University 'La Sapienza', Rome, Italy

* Corresponding author; email: belard{at}iss.it.

Chronic myelogenous leukemia (CML) is a malignant myeloproliferative disease arising from the clonal expansion of a stem cell expressing the bcr/abl oncogene. CML patients frequently respond to treatment with IFN-{alpha}, even though the mechanisms of the response remain unclear. In the present study, we evaluated the role of IFN-{alpha} in differentiation and activity of monocyte-derived dendritic cells (DCs) from CML patients as well as in modulation of the cell response to LPS. Treatment of CML monocytes with IFN-{alpha} and GM-CSF resulted in the rapid generation of activated DCs (CML-IFN-DCs), expressing IL-15 and the anti-apoptotic bcl-2 gene. These cells were fully competent to induce IFN-{gamma} production by co-cultured autologous T lymphocytes and expansion of CD8+ T cells. LPS treatment of CML-IFN-DCs, but not of immature DCs generated in the presence of IL-4/GM-CSF, induced the generation of CD8+ T cells reactive against autologous leukemic CD34+ cells. Altogether, these results suggest that: i) the generation of highly active monocyte-derived DCs could be important for the induction of an antitumor response in IFN-treated CML patients; ii) IFN-{alpha}can represent a valuable cytokine for the rapid generation of active monocyte-derived DCs to be utilized for vaccination strategies of CML patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Scutera, T. Fraone, T. Musso, P. Cappello, S. Rossi, D. Pierobon, Z. Orinska, R. Paus, S. Bulfone-Paus, and M. Giovarelli
Survival and Migration of Human Dendritic Cells Are Regulated by an IFN-{alpha}-Inducible Axl/Gas6 Pathway
J. Immunol., September 1, 2009; 183(5): 3004 - 3013.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. F. Martin, J. C. Dudda, E. Bachtanian, A. Lembo, S. Liller, C. Durr, M. M. Heimesaat, S. Bereswill, G. Fejer, R. Vassileva, et al.
Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity
J. Exp. Med., September 1, 2008; 205(9): 2151 - 2162.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Dauer, K. Schad, J. Junkmann, C. Bauer, J. Herten, R. Kiefl, M. Schnurr, S. Endres, and A. Eigler
IFN-{alpha} promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4
J. Leukoc. Biol., August 1, 2006; 80(2): 278 - 286.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Boissel, P. Rousselot, E. Raffoux, J.-M. Cayuela, J. Soulier, N. Mooney, D. Charron, H. Dombret, A. Toubert, and D. Rea
Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation
J. Leukoc. Biol., April 1, 2006; 79(4): 747 - 756.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Terme, C. Borg, F. Guilhot, C. Masurier, C. Flament, E. F. Wagner, S. Caillat-Zucman, A. Bernheim, A. G. Turhan, A. Caignard, et al.
BCR/ABL Promotes Dendritic Cell-Mediated Natural Killer Cell Activation
Cancer Res., July 15, 2005; 65(14): 6409 - 6417.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Carbonneil, H. Saidi, V. Donkova-Petrini, and L. Weiss
Dendritic cells generated in the presence of interferon-{alpha} stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells
Int. Immunol., July 1, 2004; 16(7): 1037 - 1052.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020